Abstract
We describe an elderly man who presented with hypercalcemia associated with suppressed intact parathyroid hormone (PTH) levels. Despite renal insufficiency the circulating 1,25-di-hydroxyvitamin D (1,25(OH)2D) was in the upper part of the normal range. Known causes of hypercalcemia were absent and mild hypercalcemia with suppression of intact PTH persisted until after bilateral hip replacement for severe arthritis (1 year after presentation). After hip replacement the ionized calcium normalized, intact PTH normalized, and 1,25(OH)2D decreased markedly. We believe the abnormalities in mineral homeostasis were related to production of 1,25(OH)2D by inflammatory mononuclear cells associated with arthritis.
Similar content being viewed by others
References
Barbour G.L., Coburn J.W., Slatopolsky E., Norman A.W. Horst R.L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N. Engl. J. Med. 305:440, 1981.
Gkonos P.J., London R., Hendler E.D. Hypercalcemia and elevated 1,25-dihydroxyvitamin D. levels in a patient with end-stage renal disease and active tuberculosis. N. Engl. J. Med. 311:1683, 1984.
Breslau N.A., McGuire J.L., Zerwekh J.E., Frenkel E.P., Pak C.Y.C. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann. Intern. Med. 100:1, 1984.
Kantarjian H.F., Saad M.F., Estey E.H., Sellin R.V., Samaan N.A. Hypercalcemia in disseminated candidiasis. Am. J. Med. 74:721, 1983.
Gates S., Shary J., Turner R.T., Wallach S., Bell N.H. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis. J. Bone Miner. Res. 1:221, 1986.
Adams J.S., Singer F.R., Gacad M.A., Sharma O.P., Hayes M.J., Vouros P., Holick M.F. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J. Clin. Endocrinol. Metab. 60:960, 1985.
Cadranel J., Garabedian M., Milleron M., Guillozo H., Akoun G., Hance A.J. 1,25(OH)2D3 production by T lymphocytes and alveolar macrophages recovered by lavage from nor-mocalcemic patients with tuberculosis. J. Clin. Invest. 85:1588, 1990.
Hayes M.E., O’Donoghue D.J., Ballardie F.W., Mawer E.B. Peritonitis induces the synthesis of 1α,25-dihydrox-yvitamin D3 in macrophages from CAPD patients. FEBS Lett. 220: 307, 1987.
Reichel H., Koeffler H.P., Bishop J.E., Norman A.W. 25-Hydroxyvitamin D3 metabolism by lipopolysac-charide-stimulated normal human macrophages. J. Clin. Endocrinol. Metab. 64:1, 1987.
Reichel H., Koeffler H.P., Norman A.W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320:980, 1989.
Portale A.A., Halloran B.P., Murphy M.M., Morris R.C. Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J. Clin. Invest. 77:7, 1986.
Trechsel U., Eisman J.A., Fischer J.A., Bonjour J.P., Fleisch H. Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D. Am. J. Physiol. 239: E119, 1980.
Bushinsky D.A., Riera G.S., Favus M.J., Coe F.L. Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone in the rat. J. Clin. Invest. 76:1599, 1985.
Hulter H.N., Halloran H.B., Toto R.D., Peterson J.C. Long-term control of plasma calcitriol concentration in dogs and humans; dominant role of plasma calcium concentration in experimental hyperparathyroidism. J. Clin. Invest. 76:695, 1985.
Bonjour J.P., Trechsel U., Fleisch H. Parathyrois hormone-independent regulation of 1,25(OH)2D in response to inhibition of bone resorption. Am. J. Physiol. 254: E260, 1980.
Breslau N.A., Weinstock R.S. Regulation of 1,25(OH)2D synthesis in hypoparathyroidism and pseudohypoparathyroidism. Am. J. Physiol. 255: E 730, 1988.
Miura R., Yumita S., Yoshinaga K., Furukawa Y. Response of plasma 1,25-dihydroxyvitamin D in the human PTH (1–34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism. Calcif. Tissue Int. 46:309, 1990.
Ryzen E., Rea T.H., Singer F.R. Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentration in leprosy. Am. J. Med. 84:325, 1988.
Adams J.S., Diz M.M., Sharma O.P. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann. Intern. Med. 111:437, 1989.
DeSimone D.P., Brilliant H.L., Basile J., Bell N.H. Granulomatous infiltration of the talus and abnormal vitamin D and calcium metabolism in a patient with sarcoidosis: successful treatment with hydroxychloroquine. Am. J. Med. 67:694, 1989.
Adams J.S., Sharma O.P., Diz M.M., Endres D.B. Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J. Clin. Endocrinol. Metab. 70: 1090, 1990.
Stewart A.F., Adler M., Byers C.M., Segre G.V., Broadus A.E. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N. Engl. J. Med. 666:1136, 1982.
Mason R.S., Frankel T., Chan Y., Lissner D., Posen S. Vitamin D conversion by sarcoid lymph node ho-mogenate. Ann. Intern. Med. 100:59, 1984.
Adams J.S., Modlin R.L., Diz M.M., Barnes P.F. Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. J. Clin. Endocrinol. Metab. 69:457, 1989.
Kozeny G.A., Barbato A.L., Bansal V.K., Vertuno L.L., Hano J.E. Hypercalcemia associated with silicone-induced granulomas. N. Engl. J. Med. 311:1103, 1984.
Grote T.H., Hainsworth J.D. Hypercalcemia and elevated serum calcitriol in a patient with seminoma. Arch. Intern. Med. 147:2212, 1987.
Scheinman S.J., Kelberman M.W., Tatum A.H., Zamkoff K.W. Case report: Hypercalcemia with excess serum 1,25 dihydroxyvitamin D in lymphomatoid granulomato-sis/angiocentric lymphoma. Am. J. Med. Sci. 301:178, 1991.
Kennedy B.F., Rooney P.J., Watson M.E., Fairney A., Buchanan K.D., Hillyard C.J. Hypercalcemia in rheumatoid arthritis: investigation of its causes and complications. Ann. Rheumat. Dis. 38:401, 1979.
Wouters J.M.G.W., Froeling P.G.A., Van De Putte L.B.A. Adult-onset Still’s disease complicated by hypercalcaemia: possible relationship with rapidly destructive polyarthritis. Ann. Rheumat. Dis. 44:345, 1985.
Hayes M.E., Denton J., Freemont A.J., Mawer E.B. Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. Ann. Rheumat. Dis. 48: 723, 1989.
Mawer E.B., Still P.E., Palit J., Holt P.J.L. Chloroquine lowers serum 1,25-dihydroxyvitamin in patients with inflammatory arthritis. J. Bone Miner. Res. 5(Suppl 2): no. 232, 1990 (abstract).
Mawer E.B., Hayes M.E., Still P.E., Davies M., Lumb G.A., Palit J., Holt P.J.L. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J. Bone Miner. Res. 6:733, 1991.
Hayes M.E., Davies M., Bayley D., Yin J.A.L., Mawer E.B. Synthesis of 1,25-dihydroxyvitamin D3 by spleen cells isolated from two patients with myelofibrosis and a normal subject. J. Steroid Biochem. 35:191, 1990.
Author information
Authors and Affiliations
Additional information
Presented in part at the Sixth Annual Meeting of the Adult Bone and Mineral Working Group (American Society for Bone and Mineral Research Meeting), San Diego, California, 1991.
Rights and permissions
About this article
Cite this article
Shaker, J.L., Auger, G.E., Wendt, P.P. et al. Hypercalcemia associated with dysregulation of 1,25-dihydroxyvitamin D in arthritis. J Endocrinol Invest 15, 771–776 (1992). https://doi.org/10.1007/BF03347650
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347650